Glycosaminoglycans : Anticoagulant and Nonanticoagulant Actions
Active Conformations of Glycosaminoglycans. NMR Determination of the Conformation of Heparin Sequences Complexed with Antithrombin and Fibroblast Growth Factors in Solution
Chemical Derivatization as a Strategy to Study Structure-Activity Relationships of Glycosaminoglycans
Low-Molecular-Weight Heparin and Dermatan Sulfate End Group-Labeled with Tyramine and Fluorescein. Biochemical and Biological Characterization of the Fluorescent-Labeled Heparin Derivative
Effects of Calcium Ions on the Interactions between Antithrombin and Factor Xa Mediated by Variously Sulfated, Semisynthetic Low-Molecular-Weight Heparins
Monitoring of Anticoagulant Effects of Direct Thrombin Inhibitors
Pharmacokinetic and Pharmacodynamic Characterization of a Medium-Molecular-Weight Heparin in Comparison with UFH and LMWH
Comparative Antithrombotic Potencies of Direct Thrombin Inhibitors and Low-Molecular-Weight Heparins in an Ex Vivo Human Experimental Thrombosis Model
Inhibition of B16-BL6 Melanoma Lung Colonies by Semisynthetic Sulfaminoheparosan Sulfates from E. coli K5 Polysaccharide
The Synthetic Pentasaccharide Fondaparinux : First in the Class of Antithrombotic Agents that Selectively Inhibit Coagulation Factor Xa